BioCatalystWatch
AMLXWorkspace / AMLX / OverviewCompany library
Amylyx Pharmaceuticals, Inc. logo

Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. (AMLX)

Website

Featured programme · AMX0035

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

AMX0318

GLP-1 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

AMX0035

Bax

PreINDP1P2P3FilingApproved
AMX0114

Calpain-2 (CAPN2)

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

AMX0318

GLP-1 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

AMX0035

Bax

PreINDP1P2P3FilingApproved
AMX0114

Calpain-2 (CAPN2)

PreINDP1P2P3FilingApproved

Other pipelines

History / paused

AMX0035

Bax

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

AMLX PR & News

PR & News

AMLX SEC archive